Literature DB >> 10233747

A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes.

T C Martins1, A P Aguas.   

Abstract

Non-obese diabetic (NOD) mice spontaneously develop autoimmune insulin-dependent diabetes mellitus (IDDM). Infection of the animals with mycobacteria, or immunization with mycobacteria-containing adjuvant, results in permanent protection of NOD mice from diabetes and we have recently reported that the phenomenon is associated with increased numbers of interferon-gamma-producing T cells, possessing increased cytotoxic activity, and also with augmented numbers of activated immunoglobulin M-positive (IgM+) B cells. Here, we have investigated whether protection of NOD mice from IDDM was associated with changes on costimulatory pathways of T and B cells, namely CD28/CTLA-4-B7 and CD40-CD40 ligand (CD40L) and we also further characterized protective T helper (Th) cells with regards to the expression of the differentiation markers CD45RB and CD38. We report that Th cells involved in diabetes vaccination of NOD mice by mycobacterial infection seem to belong to CD45RBlo CD38+ phenotype. The protective effect of Mycobacterium avium infection is also associated with increased CD40L and CTLA-4- expressing Th cells and with the generation of a CD40- IgG+ B cells. Our data are consistent with induction by mycobacterial infection of regulatory CD45RBlo CD38+ Th cells with the ability to trigger deletion or anergy of peripheral self-reactive lymphocytes, with shutting down of IgG+ B-cell response. They also implicate a role for IgG+ B cells in the autoimmune aggression of the endocrine pancreas of NOD mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233747      PMCID: PMC2326776          DOI: 10.1046/j.1365-2567.1999.00725.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

Review 1.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 2.  The anatomy of T-cell activation and tolerance.

Authors:  A Mondino; A Khoruts; M K Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 3.  Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases.

Authors:  H Reiser; M J Stadecker
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

Review 4.  The Yin and Yang of T cell costimulation.

Authors:  J P Allison; M F Krummel
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

5.  CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of alpha beta TCR+CD4-CD8- thymocytes.

Authors:  A G Bean; D I Godfrey; W G Ferlin; L Santos-Argumedo; M E Parkhouse; M C Howard; A Zlotnik
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

6.  A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.

Authors:  H S Han; H S Jun; T Utsugi; J W Yoon
Journal:  J Autoimmun       Date:  1996-06       Impact factor: 7.094

7.  Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse.

Authors:  A Shimada; P Rohane; C G Fathman; B Charlton
Journal:  Diabetes       Date:  1996-01       Impact factor: 9.461

8.  CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.

Authors:  A Oxenius; K A Campbell; C R Maliszewski; T Kishimoto; H Kikutani; H Hengartner; R M Zinkernagel; M F Bachmann
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

9.  A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.

Authors:  F Powrie; J Carlino; M W Leach; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.

Authors:  Z Wang; J D Davies
Journal:  Int Immunopharmacol       Date:  2006-11-28       Impact factor: 4.932

3.  A novel role for CD4+ T cells in the control of cachexia.

Authors:  Zhuangzhi Wang; Chunfang Zhao; Rosa Moya; Joanna D Davies
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice.

Authors:  Wendy Gaisford; David I Pritchard; Anne Cooke
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

5.  Cachexia in the non-obese diabetic mouse is associated with CD4+ T-cell lymphopenia.

Authors:  Chunfang Zhao; Zhuanzhi Wang; Michael W Robertson; Joanna D Davies
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

Review 6.  Autoimmunity and inflammation: murine models and translational studies.

Authors:  Samuel W Hall; Anne Cooke
Journal:  Mamm Genome       Date:  2011-06-19       Impact factor: 2.957

Review 7.  Targeting CD38 in Neoplasms and Non-Cancer Diseases.

Authors:  Wojciech Szlasa; Jakub Czarny; Natalia Sauer; Katarzyna Rakoczy; Natalia Szymańska; Jakub Stecko; Maksymilian Kołodziej; Maciej Kaźmierczak; Ewa Barg
Journal:  Cancers (Basel)       Date:  2022-08-28       Impact factor: 6.575

Review 8.  CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies.

Authors:  Fabio Morandi; Irma Airoldi; Danilo Marimpietri; Cristiano Bracci; Angelo Corso Faini; Roberto Gramignoli
Journal:  Cells       Date:  2019-11-27       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.